Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucagon 500micrograms/0.1ml inj pf disposable devices
0601040H0AAAGAG
|
Glucagon | Glucagon | Endocrine System | 228 |
|
Half Beta-Prograne 80mg modified-release capsules (Accord)
0204000R0BNAEAA
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 228 |
|
Mirapexin 1.05mg modified-release tablets
0409010W0BBAGAG
|
Mirapexin | Pramipexole | Central Nervous System | 228 |
|
Monosorb XL 60 tablets (Dexcel-Pharma)
0206010K0CCAAAE
|
Monosorb | Isosorbide mononitrate | Cardiovascular System | 228 |
|
Welland drainable night drainage bag
22605606000
|
Welland drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | 228 |
|
Yemex 25micrograms/hour transdermal patches
0407020A0BVABAE
|
Yemex | Fentanyl | Central Nervous System | 228 |
|
Benacort 64micrograms nasal spray
1202010I0BEAAAF
|
Benacort | Budesonide | Ear, Nose and Oropharynx | 227 |
|
duomed soft 2easy class 2 (18-24mmHg) anklet closed toe
21270002882
|
duomed soft 2easy class 2 (18-24mmHg) anklet closed toe | Lymphoedema Garments | Appliances | 227 |
|
Gauze swab type 13 light BP 1988 8ply non-sterile 7.5cm x 7.5cm
20120000221
|
Gauze swab type 13 light BP 1988 8ply non-sterile 7.5cm x 7.5cm | Swabs | Dressings | 227 |
|
Libra sterile leg bag short tube 350ml
22502085000
|
Libra sterile leg bag short tube 350ml | Leg Bags | Incontinence Appliances | 227 |
|
Neupro 2mg/24hours transdermal patches
0409010Z0BBAAAA
|
Neupro | Rotigotine | Central Nervous System | 227 |
|
Nicotinell Mint 2mg medicated chewing gum
0410020B0BCAEBA
|
Nicotinell | Nicotine | Central Nervous System | 227 |
|
Octreotide 500micrograms/1ml solution for injection ampoules
0803043N0AAACAC
|
Octreotide acetate | Octreotide acetate | Malignant Disease and Immunosuppression | 227 |
|
OpSite Flexigrid dressing 15cm x 20cm
20030100176
|
OpSite Flexigrid dressing 15cm x 20cm | Wound Management & Other Dressings | Dressings | 227 |
|
Option stoma cap with filter and soft covering 20-50mm opaque
23903359001
|
Option stoma cap with filter and soft covering 20-50mm opaque | Stoma Caps/Dressings | Stoma Appliances | 227 |
|
Orap 4mg tablets
0402010R0BBABAB
|
Orap | Pimozide | Central Nervous System | 227 |
|
Pelican Platinum Contour convex high output ileostomy bag maxi 12-40mm clear
23603456400
|
Pelican Platinum Contour convex high output ileostomy bag maxi 12-40mm clear | Ileostomy Bags | Stoma Appliances | 227 |
|
Venladex XL 75mg tablets
0403040W0BZABAJ
|
Venladex | Venlafaxine | Central Nervous System | 227 |
|
Wegovy FlexTouch 2.4mg/0.75ml inj 3ml pre-filled pens
0601023AWBDAEAJ
|
Wegovy | Semaglutide | Endocrine System | 227 |
|
Arovi 60mg/0.6ml solution for injection pre-filled syringes
0208010D0BEACAC
|
Arovi | Enoxaparin | Cardiovascular System | 226 |
|
Belly bag with sample port
22704887003
|
Belly bag with sample port | Suspensory Systems | Incontinence Appliances | 226 |
|
Cica-Care sheet 6cm x 12cm rectangular
20031300025
|
Cica-Care sheet 6cm x 12cm rectangular | Wound Management & Other Dressings | Dressings | 226 |
|
Clear Advantage Spirit sheath style 1 standard 24mm
22303953119
|
Clear Advantage Spirit sheath style 1 standard 24mm | Incontinence Sheaths | Incontinence Appliances | 226 |
|
Microdot Lite lancets 1.8mm/28gauge
21010900836
|
Microdot Lite lancets 1.8mm/28gauge | Other Appliances | Appliances | 226 |
|
Moderma Flex soft convex ileo bag+fltr,CeraPlus s/barr,diamond/barr, Lock'n'Roll, midi 15-38mm beige
23605906183
|
Moderma Flex soft convex ileo bag+fltr,CeraPlus s/barr,diamond/barr, Lock'n'Roll, midi 15-38mm beige | Ileostomy Bags | Stoma Appliances | 226 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.